Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction

Por Weinstein-Marom, Hadas, Gross, Gideon, Levi, Michal, Brayer, Hadar, Schachter, Jacob, Itzhaki, Orit, Besser, Michal J.
Publicado no Front Immunol (2021)

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation

Por Seliktar-Ofir, Sivan, Merhavi-Shoham, Efrat, Itzhaki, Orit, Yunger, Sharon, Markel, Gal, Schachter, Jacob, Besser, Michal J.
Publicado no Front Immunol (2017)

Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia

Por Rozenbaum, Meir, Meir, Amilia, Aharony, Yarden, Itzhaki, Orit, Schachter, Jacob, Bank, Ilan, Jacoby, Elad, Besser, Michal J.
Publicado no Front Immunol (2020)

Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex

Por Greenberg, Eyal, Hajdu, Steven, Nemlich, Yael, Cohen, Ronit, Itzhaki, Orit, Jacob-Hirsch, Jasmine, Besser, Michal J., Schachter, Jacob, Markel, Gal
Publicado em 2014

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy

Por Yunger, Sharon, Bar El, Assaf, Zeltzer, Li-at, Fridman, Eddie, Raviv, Gil, Laufer, Menachem, Schachter, Jacob, Markel, Gal, Itzhaki, Orit, Besser, Michal J
Publicado no Oncoimmunology (2019)

Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions

Por Baruch, Erez Nissim, Ortenberg, Rona, Avivi, Camila, Anafi, Liat, Dick-Necula, Daniela, Stossel, Chani, Moshkovits, Yonatan, Itzhaki, Orit, Besser, Michal Judith, Schachter, Jacob, Barshack, Iris, Markel, Gal
Publicado no Oncoimmunology (2020)

Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma

Por Itzhaki, Orit, Greenberg, Eyal, Shalmon, Bruria, Kubi, Adva, Treves, Avraham J., Shapira-Frommer, Ronnie, Avivi, Camilla, Ortenberg, Rona, Ben-Ami, Eytan, Schachter, Jacob, Besser, Michal J., Markel, Gal
Publicado em 2013

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs

Por Greenberg, Eyal, Hershkovitz, Liat, Itzhaki, Orit, Hajdu, Steven, Nemlich, Yael, Ortenberg, Rona, Gefen, Nir, Edry, Liat, Modai, Shira, Keisari, Yona, Besser, Michal J., Schachter, Jacob, Shomron, Noam, Markel, Gal
Publicado em 2011

A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme

Por Galore-Haskel, Gilli, Nemlich, Yael, Greenberg, Eyal, Ashkenazi, Shira, Hakim, Motti, Itzhaki, Orit, Shoshani, Noa, Shapira-Fromer, Ronnie, Ben-Ami, Eytan, Ofek, Efrat, Anafi, Liat, Besser, Michal J., Schachter, Jacob, Markel, Gal
Publicado no Oncotarget (2015)

Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients

Por Itzhaki, Orit, Jacoby, Elad, Nissani, Abraham, Levi, Michal, Nagler, Arnon, Kubi, Adva, Brezinger, Karin, Brayer, Hadar, Zeltzer, Li-at, Rozenbaum, Meir, Vernitsky, Helly, Markel, Gal, Toren, Amos, Avigdor, Abraham, Schachter, Jacob, Besser, Michal J
Publicado no J Immunother Cancer (2020)